About Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie
Le centre hospitalier universitaire Grenoble-Alpes est un centre hospitalier universitaire français. D'une capacité totale de 2 158 lits en 2015, c'est le principal établissement hospitalier de l'agglomération grenobloise et de l'Isère.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie
During the past decade, Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on
average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie"
#1 collaborator was "AbbVie" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie
According to Clinical.Site data, the most researched conditions in "Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie" are
"Acute Myeloid Leukemia" (4 trials), "AML" (1 trials), "Breast Cancer" (1 trials), "CLL/SLL" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie" in a lesser frequency.
Clinical Trials Intervention Types at Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie
Most popular intervention types in "Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie" are "Drug" (21 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Dexamethasone" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "Trastuzumab Emtansine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie
The vast majority of trials in "Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie" are
22 trials for "All" genders.
Clinical Trials Status at Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie
Currently, there are NaN active trials in "Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie".
undefined are not yet recruiting,
5 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chu Grenoble - Hopital Albert Michallon; Departement de Cancero-Hematologie, 1 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".